DEL GIUDICE, MARIA LIVIA
 Distribuzione geografica
Continente #
NA - Nord America 93
EU - Europa 37
AS - Asia 32
AF - Africa 5
Totale 167
Nazione #
US - Stati Uniti d'America 93
SG - Singapore 30
IT - Italia 26
NG - Nigeria 4
NL - Olanda 4
SE - Svezia 4
ES - Italia 2
HK - Hong Kong 2
CI - Costa d'Avorio 1
FI - Finlandia 1
Totale 167
Città #
Chandler 23
Singapore 16
Boardman 14
Milan 9
New York 6
Ogden 6
Florence 5
Breda 4
Genoa 4
Lagos 4
Lawrence 4
Princeton 4
Medford 3
Cambridge 2
Fairfield 2
Fort Worth 2
Hong Kong 2
Port de Sagunt 2
Abidjan 1
Chicago 1
Cincinnati 1
Cologno al Serio 1
Dallas 1
Houston 1
Los Angeles 1
Pisa 1
Rome 1
San Diego 1
Santa Clara 1
Seattle 1
Springfield 1
Totale 125
Nome #
Real-Life Experience With First-Line Therapy Bortezomib Plus Melphalan and Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma Ineligible for High Dose Chemotherapy With Autologous Stem-Cell Transplantation 37
Real-life experience with pomalidomide plus low-dose dexamethasone in patients with relapsed and refractory multiple myeloma: A retrospective and prospective study 28
Joint Pain and Arthritis as First Clinical Manifestation of Systemic Amyloidosis and Multiple Myeloma: Case Report and Brief Literature Review 23
Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network 22
Real-life experience with pomalidomide plus low-dose dexamethasone in patients with relapsed and refractory multiple myeloma: A retrospective and prospective study 21
Carfilzomib plus dexamethasone in patients with relapsed and refractory multiple myeloma: A retro-prospective observational study 17
Daratumumab in AL Amyloidosis: A Real-Life Experience of the "RTM" (Regional Tuscan Myeloma Network) 9
Beyond BCMA, why GPRC5D could be the right way: treatment strategies with immunotherapy at relapse after anti-BCMA agents 7
Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated Acute Myeloid Leukemia (AML) to guide treatment strategy 7
Novel monoclonal antibodies: A really specific therapy for light chain amyloidosis 5
Novel monoclonal antibodies: A really specific therapy for light chain amyloidosis 5
Light chain deposition disease: pathogenesis, clinical characteristics and treatment strategies 3
Totale 184
Categoria #
all - tutte 1.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.126


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202220 0 0 0 0 0 0 0 0 4 0 4 12
2022/202348 4 2 1 2 12 10 0 8 6 0 3 0
2023/202485 0 4 14 12 7 7 5 0 1 1 22 12
2024/202531 2 12 10 7 0 0 0 0 0 0 0 0
Totale 184